Stay updated on Alvocidib Biomarker AML Phase 2 Clinical Trial

Sign up to get notified when there's something new on the Alvocidib Biomarker AML Phase 2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Alvocidib Biomarker AML Phase 2 Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page's Locations section has been reorganized and expanded to include Ontario, Malaga, and Wales, replacing multiple location blocks. The Revision has been updated to v3.3.3.
    Difference
    2%
    Check dated 2025-12-23T12:42:09.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.1 to v3.3.2.
    Difference
    0.0%
    Check dated 2025-12-01T16:56:07.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The page revision was updated from v3.2.0 to v3.3.1; no substantive changes to the study details are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T11:59:29.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The funding-status notice banner was removed from the page, leaving the study details displayed without that notice.
    Difference
    0.3%
    Check dated 2025-11-17T06:18:21.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    No meaningful additions or deletions were detected between the screenshots; the page continues to present the study overview, eligibility criteria, and locations as before.
    Difference
    0.3%
    Check dated 2025-11-03T00:53:15.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.
    Difference
    3%
    Check dated 2025-10-05T08:04:49.000Z thumbnail image

Stay in the know with updates to Alvocidib Biomarker AML Phase 2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Alvocidib Biomarker AML Phase 2 Clinical Trial page.